Neurons in the central nervous system have a remarkable capacity to regenerate their transected axons when provided with an appropriate growth environment. Advances in our understanding of axon regeneration have allowed the development of different experimental strategies to stimulate axon regeneration in animal models of spinal cord injury. Growth inhibitory proteins block axon regeneration in the CNS, and many of these proteins have been identified. Various methods that are now used to stimulate regeneration in the injured spinal cord are directed at overcoming the growth inhibitory environment of the CNS. Three general approaches tested in vivo stimulate regeneration in the spinal cord. First, antibodies that bind inhibitory proteins in myelin allow axon regeneration in the CNS. Second, methods that modulate neuronal intracellular signaling allow axons to grow directly on the inhibitory substrate of the CNS. Third, transplantation of cells to the lesioned spinal cord promotes repair. In this paper we review current advances in each of these research domains.
INTRODUCTION
Traumatic injury of the spinal cord that transects axon processes results in permanent functional impairment, even when the neuronal cell bodies that are located away from the injury site remain alive. At present there are no clinical treatments available to stimulate regeneration of cut axons, but with the pace of research in the field of central nervous system (CNS) axon regeneration now increasing, the application of new discoveries may not be far away. Numerous studies now show that anatomical regeneration and functional recovery are possible in rodent models of spinal cord injury. Clinical treatments that foster regeneration would be a significant improvement over present treatments that serve only to limit the extent of secondary damage caused by non-neuronal cells that invade the injury site. Spinal cord injured patients receive high doses of the steroid methylprednisolone immediately following injury to suppress an unfavorable inflammatory reaction. This drug, however, does not restore functions that are lost when axons are cut.
Several major advances in our understanding of axon regeneration have led to the ability to stimulate some axon regeneration and functional repair in animal models of spinal cord injury. In the 1980s experiments by Aguayo and colleagues to use peripheral nerve grafts that were inserted into the brain or spinal cord showed that CNS neurons have the capacity to regrow, and these studies highlighted that diverse classes of CNS neurons have the potential to regenerate when given a permissive growth environment (Aguayo et al., 1981; Bray et al., 1987a) . Another major advance in our understanding of axon regeneration in the central nervous system was the discovery by Schwab and colleagues that the CNS environment did not simply lack growth promoting molecules, but that growth inhibitory molecules existed to block axon growth (Caroni & Schwab, 1988b; Schwab et al., 1993; Schwab & Thoenen, 1985) . Experiments aimed at removing myelin in the injured region to promote re-
